Lithium salt
Lithium salts are chemical salts of
lithium used as
mood stabilizing drugs, primarily in the treatment of
bipolar disorder,
depression, and
mania; but also in treating
schizophrenia. Usually
lithium carbonate (Li
2CO
3), but sometimes the
citrate salt,
lithium citrate is used. The salt is widely distributed in the
central nervous system and interacts with a number of neurotransmitters and receptors, decreasing
noradrenaline release and increasing
serotonin synthesis.
The use of lithium salts was developed by the Australian psychiatrist John Cade, after an accidental discovery of their effects on animals led to trials on human patients.
Treatment
Lithium treatment is used to sedate overactive and euphoric patients. Initially, lithium is often used in conjunction with antipsychotic drugs as it can take a few days for lithium to have an effect. Lithium treatment is generally considered to be unsuitable for children.
Lithium Toxicity and Side Effects
Those who use lithium should receive regular blood tests and should monitor the thyroid and kidney for toxic damage. As it is a salt, lithium can cause dehydration. Dehydration, which is compounded by heat, can result in increasing lithium levels.
High doses of haloperidol, fluphenazine, or flupenthixol may be hazardous when used with lithium; irreversible toxic encephalopathy has been reported.
Lithium salts have a narrow therapeutic/toxic ratio and should therefore not be
prescribed unless facilities for monitoring plasma concentrations are
available. Patients should be carefully selected. Doses are adjusted to achieve
plasma concentrations of 0.6 to 1.2mmol Li+/litre (lower end of the
range for maintenance therapy and elderly patients) on samples taken 12 hours
after the preceding dose. Overdosage. usually with plasma concentrations over
1.5mmol Li+/litre, may be fatal and toxic effects include
tremor, ataxia, dysarthria, nystagmus, renal impairment, and
convulsions. If these potentially hazardous signs occur, treatment should be
stopped, plasma lithium concentrations redetermined, and steps taken to reverse
lithium toxicity.
Lithium toxicity is compounded by sodium depletion. Concurrent use of
diuretics that inhibit the uptake of sodium by the distal tubule (e.g.
thiazides) is hazardous and should be avoided. In mild cases withdrawal of
lithium and administration of generous amounts of sodium and fluid will reverse
the toxicity. Plasma concentrations in excess of 2.5 mmol Li+/litre
are usually associated with serious toxicity requiring emergency treatment.
When toxic concentrations are reached there may be a delay of 1 or 2 days
before maximum toxicity occurs.
In long-term use, therapeutic concentrations of lithium have been thought to
cause histological and functional changes in the kidney. The significance of
such changes is not clear but is of sufficient concern to discourage long-term
use of lithium unless it is definitely indicated. Patients should therefore be
maintained on lithium treatment after 3-5 years only if, on assessment, benefit
persists. Conventional and sustained-release tablets are available but it
should be noted that different preparations vary widely in bioavailability
and a change in the formulation used requires the same precautions as
initiation of treatment. There seem few if any reasons for preferring one or
other of the simple salts of lithium; the carbonate has
been the more widely used but the citrate is also available.
Lithium Overdosing
Signs that lithium levels within the body are too high include: confusion, diarrhea, lethargy, severe tremors, and/or an upset stomach.
Lithium and Culture
Like many other drugs, songs have been written about its perceived effects, "Lithium Sunset" by Sting and "Lithium" by Kurt Cobain among others.
The soft drink 7Up, originally named "Bib-Label Lithiated Lemon-Lime Soda", contained lithium citrate until it was reformulated in 1950.
Further reading
- McIntyre RS, Mancini DA, Parikh S, Kennedy SH. "Lithium revisited." Can J Psychiatry. 2001 May;46(4):322-7.
- Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, and others. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918–24.
External links